Eurofins Biomnis
Arlene Campbell is a Precision Oncology Specialist at Guardant Health since May 2019 and has been a Medical Science Liaison account manager at Eurofins Biomnis since August 2017, focusing on oncology education regarding Dihydropyrimidine dehydrogenase deficiency. Prior roles include Medical Science Liaison at OncoDNA and Sales and Business Development Manager at QIAGEN, where responsibilities included marketing the QuantiFERON CMV assay and initiating clinical studies. Arlene has over 20 years of experience in the pharmaceutical industry, previously serving as a Sales and Business Development Manager, contributing innovative solutions in oncology. Additional experience includes positions at Genzyme and Genzyme Europe B.V. as a Medical Science Liaison.
This person is not in the org chart
This person is not in any offices
Eurofins Biomnis
European leader in the sector of specialized medical pathology, Eurofins Biomnis carries out over 32,000 analyses per day from a range of over 2,500 available tests, including specialized tests for which the company has the appropriate authorizations. Founded in 1897 by Marcel Mérieux, Eurofins Biomnis remains the leader in the field of specialized medical pathology in France. It has kept its position through continuous technological innovation and investment, particularly in areas such as female biology, oncology and personalized medicine, as well as chromosomal and molecular genetics. The laboratory also stands out through its expertise in clinical research and biobanking, thanks to its dedicated infrastructure. With 120 years of expertise and innovation in the service of medical pathology, Eurofins Biomnis is the core of the Clinical Diagnostics division in Europe and has its eyes set on its international development.